Because new viruses, including H1N1, there is currently no vaccine is ready and available for use against this virus. At least it took five to six months to create a completely new influenza vaccine.
Currently scientists are working on the holding of new vaccines. Vaccines typically contain a form of influenza virus that is dead or weakened. These vaccines are to prepare the immune system to defend itself against infection.
Vaccines are the only way to protect humans from epidemic and pandemic influenza. The other is the antiviral drug used is biased, personal and community health maintenance.
Scientific evidence shows that regular flu vaccines, has not been able to fight influenza A H1N1.
World Health Organization (WHO) also began to enter into agreements with vaccine manufacturers around the world to begin producing vaccine. World Health Organization (WHO) to ensure that all appropriate criteria procedure vaccine production, safety, adan ready to be produced at any time if needed.
The first doses of influenza A H1N1 vaccine can be made within five to six months after the pandemic strain of the virus that causes identified.
More than 90% of global capacity currently exist in Europe and North America. However, during the last five years several other territory already biased memprodruksi influenza vaccine.
Vaccines should be stored at temperatures below the 2-8'C.
Vaccines produced made with a very high level of security.
Guillain Barre Syndrome is an acute disorder of the nervous system. Usually arise due to various infections, including influenza. Pandemic vaccines are made based on a proven srtandard. Nevertheless, this new product will lead to other risks which will affect humans with a different reaction. Therefore, the system of monitoring and investigation of serious side effects, is an integral strategy in implementing this new vaccine.
Inactivated influenza vaccine can be given when other vaccines are also provided. However, to be injected in different locations.